SOURCE: Metiscan, Inc.

Metiscan, Inc.

January 14, 2010 09:00 ET

Metiscan Signs LOI With OccuCare Medical Centers, P.A. to Develop Practice Management Software System for Pain Management Clinics

DALLAS, TX--(Marketwire - January 14, 2010) - Metiscan, Inc. (PINKSHEETS: MTIZ) announced today that it has signed a letter of intent (LOI) with OccuCare Medical Centers, P.A. , a Texas-based pain management group, to develop a practice management software system designed specifically for the needs of pain management clinics nationwide. The practice management system will be specifically designed to optimize workflow processes and billing and collections needs for pain management clinics. The LOI sets forth certain agreements and understandings establishing a general outline of terms that may be formalized in separate, definitive documents.

"This is a great opportunity for Metiscan to develop a scalable, Internet-based practice management system that will meet the needs of pain management clinics nationwide," commented Bryan A. Scott, President & CEO of Metiscan. "We anticipate that our current discussions may yield Metiscan with the exclusive right for at least 5 years to use, reproduce, sublicense and distribute the new software system."

Mr. Scott continued, "We believe pain management facilities have very limited options when selecting a practice management system that is designed specifically for their workflow needs. Collaborating with this group of pain management experts while leveraging our experience and knowledge of Healthcare IT provides us with the opportunity to build an outstanding product that will meet the market's need. Our subsidiary, FirstView EHR, will be essential in managing and servicing this new software for pain clinic customers' needs."

About Metiscan, Inc.

Metiscan, Inc. is a holding company focused on growing its organization by making key acquisitions and developing companies and emerging technologies and is currently pursuing acquisitions and other opportunities.

Metiscan operates FirstView EHR, Inc., a wholly owned subsidiary, that provides end-to-end IT services for diagnostic imaging facilities including web-based electronic healthcare records (EHR), workflow efficiency, PACS administration, long-term archiving, professional IT services and strategic consulting. Metiscan operates Schuylkill Open MRI, Inc., a majority owned subsidiary, that is an accredited independent diagnostic testing facility (IDTF) that provides Magnetic Resonance Imaging (MRI) services. Metiscan also operates Taptopia, Inc., a wholly owned subsidiary that provides design and development services for Smartphone platforms. Metiscan also operates Shoreline Employment Services, Inc., a wholly owned subsidiary that provides employment services and benefits to all of Metiscan's subsidiaries and has begun to provide its services for other companies.

For more information, please visit

Safe Harbor Statement: Certain of the statements made in this press release constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Such forward-looking statements involve known and unknown risks, uncertainties and other unknown factors that could cause Metiscan's actual results to be materially different from the historical results or from any future results expressed or implied by such forward-looking statements. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. In addition to statements that explicitly describe such risks and uncertainties, readers are urged to consider statements labeled with the terms "believes," "belief," "intends," "anticipates" or "plans" to be uncertain and forward-looking. The Company does not intend to update any of the forward-looking statements after the date of this release to conform these statements to actual results or to changes in its expectations, except as may be required by law.

Contact Information

  • Investor Relations Contact:
    Dylan Yarter
    Voice: +1 (214) 872-6570
    Email Contact